Surgery for amygdala enlargement with mesial temporal lobe epilepsy: pathological findings and seizure outcome

Noriaki Minami1, Michiharu Morino2, Takehiro Uda2

  • 1Department of Neurosurgery, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan Department of Neurosurgery, Kobe University School of Medicine, Kobe, Hyogo, Japan.

Abstract

Insights

Amygdala enlargement (AE) in mesial temporal lobe epilepsy (MTLE) shows unique pathology. Surgical interventions like amygdalohippocampectomy effectively control seizures in AE patients.

Area of Science:

  • Neurology
  • Epileptology
  • Surgical Pathology

Background:

  • Amygdala enlargement (AE) is a suspected subtype of mesial temporal lobe epilepsy (MTLE).
  • Previous research on AE primarily focused on imaging, with limited data on surgical and pathological aspects.
  • This study investigates the surgical outcomes and histopathology of AE.

Purpose of the Study:

  • To clarify the surgical outcomes and pathological findings in patients with amygdala enlargement (AE).
  • To determine the effectiveness of surgical treatment for AE in drug-resistant mesial temporal lobe epilepsy (MTLE).

Main Methods:

  • Surgical treatment of 80 drug-resistant MTLE patients was analyzed.
  • Eleven patients diagnosed with AE via MRI underwent selective amygdalohippocampectomy or amygdalotomy with hippocampal transection.
  • Histopathological evaluation of resected amygdala tissue was performed and compared to hippocampal sclerosis cases.

Main Results:

  • Pathology revealed clustering hypertrophic neurons with vacuolization in 10 of 11 AE specimens.
  • Slight gliosis was observed in nine specimens; two showed no gliotic changes.
  • Intraoperative EEG indicated abnormal sharp waves originating from the hippocampus, not the amygdala. Ten patients achieved seizure freedom post-surgery.

Conclusions:

  • Pathological hallmarks of AE include hypertrophic neurons, vacuolation, and variable gliosis.
  • Surgical procedures such as amygdalohippocampectomy or amygdalotomy with hippocampal transection are effective for seizure control in AE.